Evidence map›Paper›PMID 35079915›Full record

ArticleNeurogenetics2022

Altered pituitary morphology as a sign of benign hereditary chorea caused by TITF1/NKX2.1 mutations.

Steffi Thust, Liana Veneziano, Michael H Parkinson, Kailash P Bhatia, Elide Mantuano, Cristina Gonzalez-Robles, Indran Davagnanam, Paola Giunti

Open access · hybridAbstract read
In one paragraph

Article in Neurogenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Steffi ThustNational Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK.
Liana VenezianoInstitute of Translational Pharmacology, National Research Council of Italy, Via Fosso del Cavaliere 100, 00133, Rome, Italy.
Michael H ParkinsonAtaxia Centre, Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Kailash P BhatiaDepartment of Clinical and Motor Neuroscience, UCL Institute of Neurology, QueenSquare, London, WC1N 3BG, UK.
Elide MantuanoInstitute of Translational Pharmacology, National Research Council of Italy, Via Fosso del Cavaliere 100, 00133, Rome, Italy.
Cristina Gonzalez-RoblesAtaxia Centre, Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Indran DavagnanamBrain Repair and Rehabilitation Unit, UCL Institute of Neurology, QueenSquare, London, WC1N 3BG, UK. indran.davagnanam@nhs.net.
Paola GiuntiAtaxia Centre, Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. p.giunti@ucl.ac.uk.ORCID 0000-0003-3508-4788
National Hospital for Neurology and Neurosurgery · GBIstituto di Farmacologia Traslazionale · ITMRC Prion Unit · GBUK Dementia Research Institute · GB

Funding

Department of Health
6 · The paper itself

Abstract

Benign hereditary chorea (BHC) is a rare genetically heterogeneous movement disorder, in which conventional neuroimaging has been reported as normal in most cases. Cystic pituitary abnormalities and features of empty sella have been described in only 7 patients with BHC to date. We present 4 patients from 2 families with a BHC phenotype, 3 of whom underwent targeted pituitary MR imaging and genetic testing. All four patients in the two families displayed a classic BHC phenotype. The targeted pituitary MR imaging demonstrated abnormal pituitary sella morphology. Genetic testing was performed in three patients, and showed mutations causing BHC in three of the patients, as well as identifying a novel nonsense mutation of the TITF1/NKX2-1 gene in one of the patients. The presence of the abnormal pituitary sella in two affected members of the same family supports the hypothesis that this sign is a distinct feature of the BHC phenotype spectrum due to mutations in the TITF1 gene. Interestingly, these abnormalities seem to develop in adult life and are progressive. They occur in at least 26% of patients affected with Brain-lung-thyroid syndrome. As a part of the management of these patients we recommend to perform follow-up MRI brain with dedicated pituitary imaging also in adult life as the abnormality can occur years after the onset of chorea.

Indexed as

ChoreaCongenital HypothyroidismHumansMutationNuclear ProteinsThyroid Nuclear Factor 1Transcription FactorsNKX2-1 protein, humanNuclear ProteinsThyroid Nuclear Factor 1Transcription FactorsBenign hereditary choreaBrain-lung-thyroid syndromeNKX2.1Pituitary cystPituitary gland

Identifiers

PMID35079915
PMCPMC8960566
OpenAlexW4206964952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.